Adverse Events following Intramedullary Nailing in Metastatic Pathological versus Non-Pathological Femoral Shaft Fractures: A Retrospective Comparative Study

Background: Antegrade intramedullary nailing is indicated for treating metastatic pathological femoral shaft fractures. Although good functional outcomes could be obtained from internal fixation, postoperative adverse events have been reported in patients with pathological fractures and non-pathological fractures. Not only adverse events but also their consequences including, readmission and reoperation, need to be considered. Few studies have assessed the risk of postoperative adverse events, reoperation, and readmission without comparison. Therefore, this study aimed to compare the risk of in-hospital adverse events and consequences after discharge between patients with metastatic pathological and non-pathological femoral fractures undergoing intramedullary nailing.Methods: We conducted a retrospective study by extracting records from the Hospital Information System database. We accessed patients with pathological metastatic pathological and non-pathological femoral shaft fractures undergoing intramedullary nailing by the International Classification of Diseases code; from June 2006 to 2020. We then tracked the in-hospital medical and surgical adverse events postoperatively, along with the consequences after discharge. The in-hospital adverse events risk between the two groups of patients were analyzed and compared by multivariate logistic regression analysis.Results: Included patients consisted of 48 in pathological groups and 185 in non-pathological groups. Significantly higher rates of surgical and medical adverse events in patients with pathological fractures compared to patients with non-pathological fractures were observed. After adjusting for potential confounding factors in multivariate regression analysis, patients with pathological fractures had higher odds of both adverse surgical (adjusted OR 2.43, 95% CI 1.15 - 5.13) and medical adverse events (adjusted OR 2.81, 95% CI 1.13 - 7.03).Conclusions: Patients with metastatic pathological femoral shaft fractures undergoing intramedullary nailing were more likely to experience postoperative adverse events than patients with non-pathological fractures.

[1]  S. Chevret,et al.  Prevention of Pathological Fracture of the Proximal Femur: A Systematic Review of Surgical and Percutaneous Image-Guided Techniques Used in Interventional Oncology , 2019, Medicina.

[2]  J. Grauer,et al.  What Is the Adverse Event Profile After Prophylactic Treatment of Femoral Shaft or Distal Femur Metastases? , 2018, Clinical orthopaedics and related research.

[3]  K. Raskin,et al.  High Risk of Venous Thromboembolism After Surgery for Long Bone Metastases: A Retrospective Study of 682 Patients , 2018, Clinical orthopaedics and related research.

[4]  J. Wittig,et al.  What Are the Functional Results and Complications With Long Stem Hemiarthroplasty in Patients With Metastases to the Proximal Femur? , 2017, Clinical orthopaedics and related research.

[5]  K. Rolston Infections in Cancer Patients with Solid Tumors: A Review , 2017, Infectious Diseases and Therapy.

[6]  S. Watson,et al.  Risk factors for same-admission mortality after pathologic fracture secondary to metastatic cancer , 2017, Supportive Care in Cancer.

[7]  W. Obremskey,et al.  Increased risk of adverse events in management of femur and tibial shaft fractures with plating: An analysis of NSQIP data. , 2016, Journal of clinical orthopaedics and trauma.

[8]  P. Lin,et al.  Intramedullary Nailing of Femoral Diaphyseal Metastases: Is it Necessary to Protect the Femoral Neck? , 2015, Clinical orthopaedics and related research.

[9]  B. Ho,et al.  A comparison of 30-day complications following plate fixation versus intramedullary nailing of closed extra-articular tibia fractures. , 2015, Injury.

[10]  S. Greenberg,et al.  Estimating the global incidence of femoral fracture from road traffic collisions: a literature review. , 2015, The Journal of bone and joint surgery. American volume.

[11]  K. Murray,et al.  Prognostic factors following pathological fractures , 2015, ANZ journal of surgery.

[12]  M. Maybody,et al.  Embolization of Hypervascular Bone Metastases Reduces Intraoperative Blood Loss: A Case-control Study , 2014, Clinical orthopaedics and related research.

[13]  R. Lackman,et al.  Surgical Management of Metastatic Long Bone Fractures: Principles and Techniques , 2014, The Journal of the American Academy of Orthopaedic Surgeons.

[14]  C. Josten,et al.  Safety aspects in surgical treatment of pathological fractures of the proximal femur – modular endoprosthetic replacement vs. intramedullary nailing , 2013, Patient Safety in Surgery.

[15]  Z. Balogh,et al.  Population-based epidemiology of femur shaft fractures , 2013, The journal of trauma and acute care surgery.

[16]  L. L. Stern,et al.  Benefits of early intramedullary nailing in femoral metastases , 2013, International Orthopaedics.

[17]  A. Mavrogenis,et al.  Protocol of surgical treatment of long bone pathological fractures. , 2010, Injury.

[18]  J. Vincent,et al.  Management of bleeding following major trauma: an updated European guideline , 2010, Critical care.

[19]  S. Cannon,et al.  Proximal femoral replacements for metastatic bone disease: financial implications for sarcoma units , 2010, International Orthopaedics.

[20]  J. Agel,et al.  Risk factors for femoral nonunion after femoral shaft fracture. , 2009, The Journal of trauma.

[21]  J. Finkelstein,et al.  Mortality and complications following stabilization of femoral metastatic lesions: a population-based study of regional variation and outcome. , 2009, Canadian journal of surgery. Journal canadien de chirurgie.

[22]  Luiz Eduardo Moreira Teixeira,et al.  EARLY COMPLICATIONS IN THE ORTHOPEDIC TREATMENT OF BONE METASTASES , 2009, Revista brasileira de ortopedia.

[23]  R. Grimer,et al.  Modular endoprosthetic replacement for tumours of the proximal femur. , 2009, The Journal of bone and joint surgery. British volume.

[24]  L. McMahon,et al.  Mobility and other predictors of hospitalization for urinary tract infection: a retrospective cohort study , 2008, BMC geriatrics.

[25]  C. Mock,et al.  The Global Burden of Musculoskeletal Injuries: Challenges and Solutions , 2008, Clinical orthopaedics and related research.

[26]  H. Skinner,et al.  Lytic lesions in the femoral neck: Importance of location and evaluation of a novel minimally invasive repair technique , 2008, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[27]  J. Lynch,et al.  Femoral Nonunion: Risk Factors and Treatment Options , 2008, The Journal of the American Academy of Orthopaedic Surgeons.

[28]  J. Parvizi,et al.  Management of lower-extremity bone metastasis. , 2006, The Journal of bone and joint surgery. American volume.

[29]  R. Coleman Clinical Features of Metastatic Bone Disease and Risk of Skeletal Morbidity , 2006, Clinical Cancer Research.

[30]  R. Wedin,et al.  Surgical treatment of skeletal metastatic lesions of the proximal femur: endoprosthesis or reconstruction nail? , 2005, The Journal of bone and joint surgery. British volume.

[31]  M. Forster,et al.  Reaming during anterograde femoral nailing: is it worth it? , 2005, Injury.

[32]  D. Georgiannos,et al.  Breast cancer bone metastasis in femur: surgical considerations and reconstruction with Long Gamma Nail. , 2004, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[33]  F. Sim,et al.  Patient survival after hip arthroplasty for metastatic disease of the hip. , 2004, The Journal of bone and joint surgery. American volume.

[34]  W. Ward,et al.  Metastatic Disease of the Femur: Surgical Treatment , 2003, Clinical orthopaedics and related research.

[35]  K. Weber,et al.  Operative treatment of long bone metastases: focus on the femur. , 2003, Clinical Orthopaedics and Related Research.

[36]  A. Aboulafia,et al.  Incidence, location, and diagnostic evaluation of metastatic bone disease. , 2000, The Orthopedic clinics of North America.

[37]  B. Gainor,et al.  Fracture healing in metastatic bone disease. , 1983, Clinical orthopaedics and related research.